1. Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD‐VTE
- Author
-
Henri Bounameaux, Harry Gibbs, Sebastian Schellong, Alexander G.G. Turpie, Ajay K. Kakkar, Peter MacCallum, Alfredo E. Farjat, Garfield-Vte investigators, Pantep Angchaisuksiri, Shinya Goto, Samuel Z. Goldhaber, Lorenzo G. Mantovani, Gloria Kayani, Marc Carrier, Jeffrey I. Weitz, Sylvia Haas, Walter Ageno, Paolo Prandoni, Weitz, J, Farjat, A, Ageno, W, Turpie, A, Haas, S, Goto, S, Goldhaber, S, Angchaisuksiri, P, Gibbs, H, Maccallum, P, Carrier, M, Kayani, G, Schellong, S, Bounameaux, H, Mantovani, L, Prandoni, P, and Kakkar, A
- Subjects
obesity ,medicine.medical_specialty ,pulmonary embolism ,venous thromboembolism ,Hemorrhage ,body mass index ,Overweight ,Internal medicine ,medicine ,Risk of mortality ,Humans ,Prospective Studies ,anticoagulation ,business.industry ,Hazard ratio ,Anticoagulants ,nutritional and metabolic diseases ,Hematology ,medicine.disease ,Obesity ,Pulmonary embolism ,medicine.symptom ,Underweight ,business ,Body mass index ,Venous thromboembolism - Abstract
Background: There is limited information on the influence of body mass index (BMI) on clinical outcomes in patients with venous thromboembolism (VTE). Objectives: Investigate the influence of BMI on baseline characteristics, treatment patterns, and 24-month outcomes in VTE patients. Methods: GARFIELD-VTE is a prospective, non-interventional study of 10869 patients with objectively confirmed VTE. Patients were grouped according to BMI
- Published
- 2021